Product Details
| Alternative Name: | ET-3 |
| |
| Sequence: | H-Cys-Thr-Cys-Phe-Thr-Tyr-Lys-Asp-Lys-Glu-Cys-Val-Tyr-Tyr-Cys-His-Leu-Asp-Ile-Ile-Trp-OH
(Disulfide bonds between Cys1-Cys15and Cys3-Cys11) |
| |
| Formula: | C121H168N26O33S4 |
| |
| MW: | 2643.1 |
| |
| CAS: | 117399-93-6 |
| |
| MI: | 14: 3576 |
| |
| Quantity: | *Sold as net peptide weight. |
| |
| Formulation: | Lypophilized. |
| |
| Purity: | ≥98% (HPLC) |
| |
| Solubility: | Soluble in DMSO or water. |
| |
| Shipping: | Ambient Temperature |
| |
| Long Term Storage: | -20°C |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Product Literature References
Synthesis of endothelin-1 analogues, endothelin-3, and sarafotoxin S6b: structure-activity relationships: K. Nakajima, et al.; J. Cardiovasc. Pharmacol.
13, S8 (1989),
Abstract;
The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes: A. Inoue, et al.; PNAS
86, 2863 (1989),
Abstract;
Primary structure, synthesis, and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide: M. Yanagisawa, et al.; PNAS
85, 6964 (1988),
Abstract;
